University Hospital Zurich, Centre of Clinical Nursing Science
Zurich, Canton of Zurich, 8091, Switzerland
NCT Number: NCT01758562
Randomized controlled study about the efficacy of the mouth rinse Caphosol in patients with allogeneic stem cell transplantation. 85% of the patients receive a severe oral mucositis due to their treatment.
70 patients will be randomized in the intervention (Caphosol) or in the standard (state-of-the-art) group. Primary endpoint is the duration of the mucositis, secondary endpoints are the occurence of oral mucositis measured with the WHO-scale and the occurence of pain measured with the NRS-scale (Numeric Rating Scale).
* Trial with medical device
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Zurich, Canton of Zurich, 8091, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 20-30 days
University of Zurich
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04628338
Allogeneic Stem Cell Transplantation, Bone Marrow Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06093334
Acute Lymphoblastic Leukemia, Allogeneic Stem Cell Transplantation
Erlangen, Bavaria, Germany
View Trial DetailsNCT06256341
Allogeneic Stem Cell Transplantation
View Trial DetailsNCT01092026
Allogeneic Stem Cell Transplantation
Brussels, Belgium
View Trial Details